European Heart Journal最新文献

筛选
英文 中文
Clonal haematopoiesis and cardiovascular diseases: challenges and opportunities. 克隆造血与心血管疾病:挑战与机遇。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-10-17 DOI: 10.1093/eurheartj/ehaf812
Cesar De Jeronimo Diaz,Trevor P Fidler,Dina Levy-Lambert
{"title":"Clonal haematopoiesis and cardiovascular diseases: challenges and opportunities.","authors":"Cesar De Jeronimo Diaz,Trevor P Fidler,Dina Levy-Lambert","doi":"10.1093/eurheartj/ehaf812","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf812","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"12 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145305576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacoepidemiology as the delicate science of constructing robust plausibility where there is no certainty: the case for hypertension in young adults. 药物流行病学是一门精细的科学,在不确定的情况下构建强有力的合理性:年轻人高血压的情况。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-10-17 DOI: 10.1093/eurheartj/ehaf712
Antoine Pariente
{"title":"Pharmacoepidemiology as the delicate science of constructing robust plausibility where there is no certainty: the case for hypertension in young adults.","authors":"Antoine Pariente","doi":"10.1093/eurheartj/ehaf712","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf712","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"1 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145305621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond the scar: risk prediction in non-dilated left ventricular cardiomyopathy. 疤痕之外:非扩张型左室心肌病的风险预测。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-10-17 DOI: 10.1093/eurheartj/ehaf566
Elena Arbelo
{"title":"Beyond the scar: risk prediction in non-dilated left ventricular cardiomyopathy.","authors":"Elena Arbelo","doi":"10.1093/eurheartj/ehaf566","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf566","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"9 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145305638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Killing three birds with one stone: transcatheter salvage of aorto-atrial fistula and paravalvular leaks following transcatheter tricuspid valve replacement. 一石三鸟:经导管修复主动脉房瘘和经导管三尖瓣置换术后瓣旁渗漏。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-10-17 DOI: 10.1093/eurheartj/ehaf796
Yuliang Long,Daxin Zhou,Wenzhi Pan
{"title":"Killing three birds with one stone: transcatheter salvage of aorto-atrial fistula and paravalvular leaks following transcatheter tricuspid valve replacement.","authors":"Yuliang Long,Daxin Zhou,Wenzhi Pan","doi":"10.1093/eurheartj/ehaf796","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf796","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"46 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145305639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urinary tract infection and continuation of sodium-glucose cotransporter-2 inhibitors in diabetic patients. 糖尿病患者尿路感染和钠-葡萄糖共转运蛋白-2抑制剂的持续应用。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-10-17 DOI: 10.1093/eurheartj/ehaf788
Mei-Zhen Wu,Ran Guo,Chanchal Chandramouli,Lin Liu,Anthony Ma-On Tung,Christopher Tze-Wei Tsang,Yi-Kei Tse,Yap-Hang Chan,Chi-Ho Lee,Jia-Yi Huang,Jing-Nan Zhang,Wen-Li Gu,Qing-Wen Ren,Ching-Yan Zhu,Yik-Ming Hung,Carolyn S P Lam,Kai-Hang Yiu
{"title":"Urinary tract infection and continuation of sodium-glucose cotransporter-2 inhibitors in diabetic patients.","authors":"Mei-Zhen Wu,Ran Guo,Chanchal Chandramouli,Lin Liu,Anthony Ma-On Tung,Christopher Tze-Wei Tsang,Yi-Kei Tse,Yap-Hang Chan,Chi-Ho Lee,Jia-Yi Huang,Jing-Nan Zhang,Wen-Li Gu,Qing-Wen Ren,Ching-Yan Zhu,Yik-Ming Hung,Carolyn S P Lam,Kai-Hang Yiu","doi":"10.1093/eurheartj/ehaf788","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf788","url":null,"abstract":"BACKGROUND AND AIMSTo investigate the impact of incident urinary tract infection (UTI) and subsequent sodium-glucose cotransporter-2 (SGLT2) inhibitors discontinuation on clinical outcomes among patients with type 2 diabetes mellitus (T2DM) prescribed SGLT2 inhibitors.METHODSThis territory-wide cohort study analysed patients with T2DM prescribed SGLT2 inhibitors from January 2015 to June 2022. Primary outcomes included primary cardiovascular composite outcomes (heart failure hospitalization, stroke, myocardial infarction, or all-cause mortality) and primary renal composite outcomes (50% decline in estimated glomerular filtration rate [eGFR], end-stage renal failure, or all-cause mortality). The secondary outcome was recurrent UTI. A target trial emulation was applied to estimate the impact of discontinuing SGLT2 inhibitors.RESULTSAmong 61 606 eligible patients, 3921 (6.36%) had at least one UTI incidence during follow-up. Patients with incident UTI exhibited a higher risk of primary cardiovascular composite outcomes [hazards ratio (HR): 3.18, 95% confidence interval (CI): 2.88-3.51] and primary renal composite outcomes (HR: 2.51, 95% CI: 2.32-2.72) compared to those without UTI. Following a UTI, 32.31% of patients discontinued SGLT2 inhibitors. Discontinuation was associated with a higher cardiovascular (HR: 1.35, 95% CI: 1.20-1.53) and renal (HR: 1.35, 95% CI: 1.21-1.51) risks compared to continued use, while the risk of recurrent UTI was similar (HR: 0.96, 95% CI: 0.22-4.29).CONCLUSIONSNew-onset UTI was associated with an increased risk of cardiovascular and renal events in patients with T2DM prescribed SGLT2 inhibitors. Discontinuing SGLT2 inhibitors after a UTI was linked to a higher risk of cardiovascular and renal outcomes but was not associated with fewer recurrent UTI.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"1 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145305578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing the conversation of data sharing in cardiovascular clinical research. 推进心血管临床研究数据共享对话。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-10-17 DOI: 10.1093/eurheartj/ehaf730
Ankeet S Bhatt,Scott D Solomon
{"title":"Advancing the conversation of data sharing in cardiovascular clinical research.","authors":"Ankeet S Bhatt,Scott D Solomon","doi":"10.1093/eurheartj/ehaf730","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf730","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"66 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145311182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter edge-to-edge repair for atrial functional mitral regurgitation: the final frontier. 经导管边缘对边缘修复心房功能性二尖瓣反流:最终前沿。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-10-17 DOI: 10.1093/eurheartj/ehaf792
Benedict McDonaugh,Simon Redwood,Tiffany Patterson
{"title":"Transcatheter edge-to-edge repair for atrial functional mitral regurgitation: the final frontier.","authors":"Benedict McDonaugh,Simon Redwood,Tiffany Patterson","doi":"10.1093/eurheartj/ehaf792","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf792","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"62 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145305759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of moderate mixed aortic valve stenosis and regurgitation. 中度混合性主动脉瓣狭窄和反流的结局。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-10-17 DOI: 10.1093/eurheartj/ehaf791
Pilar Lopez Santi,Jérémy Bernard,Aileen Chua,Dorien Laenens,Andréanne Powers,Kathia Abdoun,Bart J J Velders,Camille Sarrazyn,Paolo Springhetti,Jingnan Zhang,Mohammed R Amanullah,See Hooi Ewe,Kai-Hang Yiu,Meindert Palmen,Jesper Hjortnaes,Philippe Pibarot,Marie-Annick Clavel,Jeroen J Bax,Nina Ajmone Marsan
{"title":"Outcomes of moderate mixed aortic valve stenosis and regurgitation.","authors":"Pilar Lopez Santi,Jérémy Bernard,Aileen Chua,Dorien Laenens,Andréanne Powers,Kathia Abdoun,Bart J J Velders,Camille Sarrazyn,Paolo Springhetti,Jingnan Zhang,Mohammed R Amanullah,See Hooi Ewe,Kai-Hang Yiu,Meindert Palmen,Jesper Hjortnaes,Philippe Pibarot,Marie-Annick Clavel,Jeroen J Bax,Nina Ajmone Marsan","doi":"10.1093/eurheartj/ehaf791","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf791","url":null,"abstract":"BACKGROUND AND AIMSThere are limited data on mortality in patients with moderate mixed aortic valve disease (MAVD), defined as the combination of moderate aortic stenosis (AS) and moderate aortic regurgitation (AR). Consequently, current guidelines lack specific recommendations for aortic valve replacement (AVR) in this population. This study aims to compare survival between moderate MAVD and isolated severe AS or severe AR, and to evaluate the impact of symptoms or left ventricular ejection fraction (LVEF) < 50%, as current criteria for AVR in severe AS or AR.METHODSOverall, 1926 patients were included from four centers: 527 with moderate MAVD, 413 with severe AR, and 986 with severe AS. The primary endpoint was all-cause mortality.RESULTSOver a median follow-up of 7.2 (interquartile range 3.4-11.3) years, 748 patients died. After adjusting for clinical and echocardiographic variables (including New York Heart Association [NYHA] class, LVEF < 50%, and AVR as time-dependent covariate), moderate MAVD patients showed 10-year survival similar to severe AS but worse than severe AR (62%, 55%, and 79%, respectively; P < .001). Symptomatic moderate MAVD patients showed adjusted mortality comparable to symptomatic severe AS, while asymptomatic moderate MAVD patients had adjusted mortality similar to severe AR (symptomatic and asymptomatic). Moderate MAVD patients with LVEF < 50% had adjusted mortality comparable to severe AS with LVEF < 50%, while those with LVEF ≥ 50% showed mortality similar to severe AR (regardless of left ventricular dysfunction).CONCLUSIONSIn moderate MAVD, the presence of symptoms or LVEF < 50% is associated with increased mortality, comparable to isolated severe AS under similar conditions. Therefore, patients with moderate MAVD should benefit from AVR in the presence of symptoms or left ventricular dysfunction.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"58 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145305640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angina after percutaneous coronary interventions. 经皮冠状动脉介入治疗后心绞痛。
IF 35.6 1区 医学
European Heart Journal Pub Date : 2025-10-17 DOI: 10.1093/eurheartj/ehaf771
Marco Lombardi, Laurie-Anne Boivin-Proulx, Adrian Jerónimo, Hernán Mejía-Rentería, Nieves Gonzalo, Tommaso Gori, Roxana Mehran, Javier Escaned
{"title":"Angina after percutaneous coronary interventions.","authors":"Marco Lombardi, Laurie-Anne Boivin-Proulx, Adrian Jerónimo, Hernán Mejía-Rentería, Nieves Gonzalo, Tommaso Gori, Roxana Mehran, Javier Escaned","doi":"10.1093/eurheartj/ehaf771","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf771","url":null,"abstract":"<p><p>Persistence or recurrence of angina after percutaneous coronary intervention (PCI) has gained recognition as an unfortunately common condition, which defeats the most frequent purpose of performing PCI in patients with stable coronary artery disease, the relief or reduction of anginal symptoms. Many aspects of this problem remain unknown and underexplored, with clinical practice guidelines providing limited information on guidance for its causative diagnosis, prevention and management. This review article aims to provide a contemporary perspective on the problem of post-PCI angina, leveraging recent advancements on the pathophysiological mechanisms that frequently underlie this condition, including sub-optimal functional results of PCI and non-obstructive causes of myocardial ischaemia. The opportunities provided by new functional coronary angiography tools are explored. A practical structured approach to the aetiological diagnosis and treatment of these patients is proposed.</p>","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":""},"PeriodicalIF":35.6,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145307333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-linear Mendelian randomization analyses on 25-hydroxyvitamin D and the risk of cardiovascular outcomes. 25-羟基维生素D与心血管疾病风险的非线性孟德尔随机化分析。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-10-17 DOI: 10.1093/eurheartj/ehaf785
Elina Hyppönen,Ang Zhou
{"title":"Non-linear Mendelian randomization analyses on 25-hydroxyvitamin D and the risk of cardiovascular outcomes.","authors":"Elina Hyppönen,Ang Zhou","doi":"10.1093/eurheartj/ehaf785","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf785","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"104 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145305575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信